Published 2019-07-02
Aditya Pramanta Johan Renaldo Doddy M Soebadi


Objective: The patency rates after vasectomy reversal ranges from 71-97%, but there is 26-72% possibility of persistent infertility. Dysfunction or obstruction of the epididymis and oxidative stress are thought to be the important cause of male infertility by disrupting spermatozoa maturation process, causing poor sperm quality. Human erythropoietin or better known as EPO is a glycoprotein hormone that has been purified since three decades ago. Research on the EPO has evolved and become a major research topic the researchers aimed as a therapeutic agent. The cloning and expression of erythropoietin has developed recombinant erythropoietin as a drug that serves as an anti-oxidant, anti-apoptotic and anti-inflammatory. This study aimed to determine the effect of erythropoietin supplementation on sperm motility and morphology in Wistar rat after the release of the vas deferens’ ligation. Material & Methods: Twenty four male Wistar rats were randomly divided into four groups (6 each). On the vasectomy group, the vas deferens were serially ligated for 7 weeks using a non-absorbable suture. The vasectomy reversal group get the same surgical treatment and after 7 weeks the ligation were released. While as in the erythropoietin group, recombinant eryhtropoietin (1000 IU/kg) was administered intraperitoneally three times for 1 week after releasing the ligation. Normal control animals received no surgical manipulation and followed by sperm retrieval for analysis. Eosin-stained slides were prepared to assess the motility and morphology of sperm cells and observed under a light microscope. Results: Ligation of vas deferens significantly decreased sperm motility and morphology. Releasing the ligation of the vas deferens did not improve the sperm motility and morphology. Supplementing eryhtropoietin 1000 IU/kg 3 times for a week after releasing the ligation did not improve the sperm motility and morphology. Conclusion: Erythropoietin supplementation did not improve the sperm motility and morphology in Wistar rat after releasing the ligation of vas deferens.



Vasectomy, reversal, eryhtropoietin, sperm motility, sperm morphology


Kolettis PN, Sharma RK, Pasqualotto FF, Nelson D, Thomas J, Agarwal A. Effect of seminal oxidative stress on fertility after vasectomy reversal. Fertil Steril. 1999; 71(2): 249–55.

Temma K, Shimoya K. Detection of erythropoietin in human. 2004; 81(March): 798–801.

Tug N, Altunkaynak ME, Aktas RG, Kilic U, Yilmaz B, Cam C, et al. Does erythropoietin affect motility of spermatozoa? Arch Gynecol Obstet. 2010; 281(5): 933–8.

Zhang Y, Wang L, Dey S, Alnaeeli M, Suresh S, Rogers H, et al. Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci. 2014; 15(6): 10296–333.

Köseoğlu B, Yılmaz E, Ceylan K, Uzun E, Bayram İ, Hızlı F. The protective effect of erythropoietin infusion on testicular torsion/detorsion: An experimental study. Int Urol Nephrol. 2009; 41(1): 85–91.

Turner TT BK. Spermatic cord torsion: Loss of spermatogenesis despite return of blood flow. Biol Reprod. 1993; 49(2): 401-7.

EA MJA AC P, HN H-LDJ SP V, CM B. Effect of antioxidant supplementation in semen extenders on semen quality and reactive oxygen species of chilled canine spermatozoa. Anim Reprod Sci. 2009; 112: 119-35.

M SD K. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol. 2004; 2: 12.

Katavetin P, Tungsanga K, Eiam-Ong S, Nangaku M. Antioxidative effects of erythropoietin. Kidney Int. 2007; 72(Suppl. 107).

Bailey DM, Lundby C, Berg RMG, Taudorf S, Rahmouni H, Gutowski M, et al. On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiologica. 2014; 212: 175-87.

Shapiro RH, Muller CH, Chen G, Berger RE. Vasectomy reversal associated with increased reactive oxygen species production by seminal fluid leukocytes and sperm. J Urol. 1998; (August 2014): 1341–6.

RK Sharma, FF Pasqualotto, H Kobayashi, AJ Thomas J, AA. Oxidative stress and IL-6 levels in patients undergoing vasectomy reversal. Cent Adv Res Hum Reprod Infertil Dep Urol Clevel Clin Found Cleveland, OH. 2005; 89.

Flickinger CJ. Alterations in the fine structure of the rat epididymis after vasectomy. Anat Rec [Internet]. 1972; 173(3): 277–99. Available from: 4339005.

Hamed MG, Ahmed RM, Maher M MM. Effect of erythropoietin on experimental unilateral testicular torsion detorsion in rat model. Egypt. 2011; 8(2): 405–12.

Collares TF, Campos VF, Urtiaga G, Leon PMM, Amaral MG, Hartleben CP, et al. Erythropoietin non-viral gene therapy does not affect motility, viability, morphology or concentration of rabbit sperm. Animal. 2013; 7(5): 778–83.

Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University